These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 22173164)

  • 21. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholangiocarcinoma: the "other" liver cancer on the rise.
    Davila JA; El-Serag HB
    Am J Gastroenterol; 2002 Dec; 97(12):3199-200. PubMed ID: 12492212
    [No Abstract]   [Full Text] [Related]  

  • 23. Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017.
    Javle M; Lee S; Azad NS; Borad MJ; Kate Kelley R; Sivaraman S; Teschemaker A; Chopra I; Janjan N; Parasuraman S; Bekaii-Saab TS
    Oncologist; 2022 Oct; 27(10):874-883. PubMed ID: 35972334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do increases in mortality from intrahepatic cholangiocarcinoma reflect a genuine increase in risk? Insights from cancer registry data in Scotland.
    Wood R; Brewster DH; Fraser LA; Brown H; Hayes PC; Garden OJ
    Eur J Cancer; 2003 Sep; 39(14):2087-92. PubMed ID: 12957464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Classification and staging systems for hilar cholangio-carcinoma (Klatskin tumors): clinical application and practical relevance].
    Gavrilovici V; Grecu F; Seripcariu V; Dragomir C
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):412-7. PubMed ID: 21870733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer of the Larynx-20-Year Comparative Survival and Mortality Analysis by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration and ICD-O-3 Topographic Primary Sites-Codes C32.0-9: A Systematic Review of 43,103 Cases for Diagnosis Years 1975-2017: (NCI SEER*Stat 8.3.9).
    Milano AF
    J Insur Med; 2024 Jul; 51(2):92-110. PubMed ID: 39266004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise.
    Saha SK; Zhu AX; Fuchs CS; Brooks GA
    Oncologist; 2016 May; 21(5):594-9. PubMed ID: 27000463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gall bladder cancer, extrahepatic bile duct cancer and ampullary carcinoma in New Zealand: Demographics, pathology and survival.
    Koea J; Phillips A; Lawes C; Rodgers M; Windsor J; McCall J
    ANZ J Surg; 2002 Dec; 72(12):857-61. PubMed ID: 12485219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of quadrant-specific breast cancer incidence trends in the United States and England between 1975 and 2013.
    Bright CJ; Rea DW; Francis A; Feltbower RG
    Cancer Epidemiol; 2016 Oct; 44():186-194. PubMed ID: 27632243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholangiocarcinoma--current treatment options.
    Friman S
    Scand J Surg; 2011; 100(1):30-4. PubMed ID: 21491796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term trends in incidence and mortality of intrahepatic and extrahepatic bile duct cancer in Japan.
    Utada M; Ohno Y; Tamaki T; Sobue T; Endo G
    J Epidemiol; 2014; 24(3):193-9. PubMed ID: 24614916
    [TBL] [Abstract][Full Text] [Related]  

  • 32.  Intrahepatic, perihilar and distal cholangiocarcinoma: Management and outcomes.
    Waseem D; Tushar P
    Ann Hepatol; 2017 Jan-Feb 2017; 16(1):133-139. PubMed ID: 28051802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current epidemiology of cholangiocarcinoma in Western countries.
    Vithayathil M; Khan SA
    J Hepatol; 2022 Dec; 77(6):1690-1698. PubMed ID: 35977611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New staging system and a registry for perihilar cholangiocarcinoma.
    Deoliveira ML; Schulick RD; Nimura Y; Rosen C; Gores G; Neuhaus P; Clavien PA
    Hepatology; 2011 Apr; 53(4):1363-71. PubMed ID: 21480336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Gallbladder and bile duct carcinoma. Biology and pathology].
    Tannapfel A; Wittekind C
    Internist (Berl); 2004 Jan; 45(1):33-41. PubMed ID: 14735242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012.
    Florio AA; Ferlay J; Znaor A; Ruggieri D; Alvarez CS; Laversanne M; Bray F; McGlynn KA; Petrick JL
    Cancer; 2020 Jun; 126(11):2666-2678. PubMed ID: 32129902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
    Milano AF
    J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Geographic variation of intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, and hepatocellular carcinoma in the United States.
    Altekruse SF; Petrick JL; Rolin AI; Cuccinelli JE; Zou Z; Tatalovich Z; McGlynn KA
    PLoS One; 2015; 10(3):e0120574. PubMed ID: 25837669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age trends in biliary tract cancer incidence by anatomical subtype: A Swedish cohort study.
    Rahman R; Ludvigsson JF; von Seth E; Lagergren J; Bergquist A; Radkiewicz C
    Eur J Cancer; 2022 Nov; 175():291-298. PubMed ID: 36174301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrahepatic cholangiocarcinoma: new insights in pathology.
    Sempoux C; Jibara G; Ward SC; Fan C; Qin L; Roayaie S; Fiel MI; Schwartz M; Thung SN
    Semin Liver Dis; 2011 Feb; 31(1):49-60. PubMed ID: 21344350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.